StockData
Bausch Health Companies Inc. logo

Bausch Health Companies Inc. (BHC) stock

BHCNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 8/3077% below fair value
$8.47+0.05 (+0.59%)

Close on Nov 17, 2026Market cap $3.17BP/E –Yield –

Bausch Health Companies total assets

Total assets on the balance sheet at the end of each period.

Bausch Health Companies's total assets was $25.48B at Sep 30, 2026. For fiscal 2025 it was $26.37B, down 0.6% from the year before. Over ten years it grew -6.0% a year on average. The highest annual figure on record is $48.97B in fiscal 2015.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$26.37B-0.6%
FY2024Dec 31, 2024$26.52B-3.0%
FY2023Dec 31, 2023$27.35B+6.5%
FY2022Dec 31, 2022$25.69B-12.0%
FY2021Dec 31, 2021$29.20B-6.4%
FY2020Dec 31, 2020$31.20B-7.9%
FY2019Dec 31, 2019$33.86B+4.2%
FY2018Dec 31, 2018$32.49B-13.3%
FY2017Dec 31, 2017$37.50B-13.9%
FY2016Dec 31, 2016$43.53B-11.1%
FY2015Dec 31, 2015$48.97B+86.1%
FY2014Dec 31, 2014$26.30B-5.8%
FY2013Dec 31, 2013$27.93B+55.6%
FY2012Dec 31, 2012$17.95B+36.9%
FY2011Dec 31, 2011$13.11B+21.4%
FY2010Dec 31, 2010$10.80B+424.2%
FY2009Dec 31, 2009$2.06B–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$25.48B-5.0%
Q2 FY2026Jun 30, 2026$24.79B-9.1%
Q1 FY2026Mar 31, 2026$24.50B-7.3%
Q4 FY2025Dec 31, 2025$26.37B-0.6%
Q3 FY2025Sep 30, 2025$26.82B+1.1%
Q2 FY2025Jun 30, 2025$27.27B+2.9%
Q1 FY2025Mar 31, 2025$26.42B-1.8%
Q4 FY2024Dec 31, 2024$26.52B-3.0%
Q3 FY2024Sep 30, 2024$26.54B-1.9%
Q2 FY2024Jun 30, 2024$26.50B+3.9%
Q1 FY2024Mar 31, 2024$26.91B+5.8%
Q4 FY2023Dec 31, 2023$27.35B+6.5%
Q3 FY2023Sep 30, 2023$27.06B+2.9%
Q2 FY2023Jun 30, 2023$25.50B-9.5%
Q1 FY2023Mar 31, 2023$25.45B-12.5%
Q4 FY2022Dec 31, 2022$25.69B-12.0%
Q3 FY2022Sep 30, 2022$26.30B-10.1%
Q2 FY2022Jun 30, 2022$28.17B-6.2%
Q1 FY2022Mar 31, 2022$29.09B-3.7%
Q4 FY2021Dec 31, 2021$29.20B-6.4%
Q3 FY2021Sep 30, 2021$29.25B-7.3%
Q2 FY2021Jun 30, 2021$30.04B-4.3%
Q1 FY2021Mar 31, 2021$30.20B-5.2%
Q4 FY2020Dec 31, 2020$31.20B-7.9%
Q3 FY2020Sep 30, 2020$31.56B-0.3%
Q2 FY2020Jun 30, 2020$31.40B-3.0%
Q1 FY2020Mar 31, 2020$31.87B-2.1%
Q4 FY2019Dec 31, 2019$33.86B+4.2%
Q3 FY2019Sep 30, 2019$31.67B-6.2%
Q2 FY2019Jun 30, 2019$32.35B-6.1%
Q1 FY2019Mar 31, 2019$32.55B-9.1%
Q4 FY2018Dec 31, 2018$32.49B-13.3%
Q3 FY2018Sep 30, 2018$33.78B-15.5%
Q2 FY2018Jun 30, 2018$34.45B-17.5%
Q1 FY2018Mar 31, 2018$35.80B-15.4%
Q4 FY2017Dec 31, 2017$37.50B-13.9%
Q3 FY2017Sep 30, 2017$39.97B–
Q2 FY2017Jun 30, 2017$41.73B–
Q1 FY2017Mar 31, 2017$42.33B–
Q4 FY2016Dec 31, 2016$43.53B–

More Bausch Health Companies figures

See a number that looks wrong?